Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Angiosarcoma
Researchers at Brigham and Women's Hospital target angiosarcoma
January 29th, 2009
According to a study from the United States, "Mammary angiosarcoma is a rare neoplasm, accounting for about 0.05%, of all primary malignancies of the breast. It is currently believed that histologic grading of mammary angiosarcomas plays an important role in prognostication." "Forty-nine cases of primary angiosarcoma of the breast were retrieved from our files. Clinical details and follow-up information were obtained from referring pathologists and clinicians. and by chart review. All statistics were performed using Fisher exact test and only P< 0.05 was considered significant. Recurrence-free survival and overall survival Curves were established using Statistica...
Source: Women's Health Weekly (2009-01-29)
|
